HighTower Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Buy |
188,878
+111,312
| +144% | +$191K | ﹤0.01% | 2851 |
|
|
2025
Q1 | $258K | Sell |
77,566
-1,672
| -2% | -$5.57K | ﹤0.01% | 2968 |
|
|
2024
Q4 | $586K | Buy |
79,238
+2,951
| +4% | +$21.8K | ﹤0.01% | 2341 |
|
|
2024
Q3 | $716K | Buy |
76,287
+84
| +0.1% | +$788 | ﹤0.01% | 2137 |
|
|
2024
Q2 | $611K | Buy |
+76,203
| New | +$611K | ﹤0.01% | 2168 |
|
|
2022
Q3 | – | Sell |
-12,050
| Closed | -$132K | – | 3015 |
|
|
2022
Q2 | $132K | Buy |
12,050
+769
| +7% | +$8.42K | ﹤0.01% | 2699 |
|
|
2022
Q1 | $189K | Buy |
11,281
+845
| +8% | +$14.2K | ﹤0.01% | 2825 |
|
|
2021
Q4 | $198K | Sell |
10,436
-658
| -6% | -$12.5K | ﹤0.01% | 2763 |
|
|
2021
Q3 | $275K | Sell |
11,094
-3,093
| -22% | -$76.7K | ﹤0.01% | 2464 |
|
|
2021
Q2 | $368K | Buy |
+14,187
| New | +$368K | ﹤0.01% | 2229 |
|
|
2020
Q2 | – | Sell |
-7,535
| Closed | -$227K | – | 2269 |
|
|
2020
Q1 | $227K | Buy |
+7,535
| New | +$227K | ﹤0.01% | 1702 |
|
|
2019
Q3 | – | Sell |
-13,103
| Closed | -$308K | – | 2310 |
|
|
2019
Q2 | $308K | Buy |
+13,103
| New | +$308K | ﹤0.01% | 1781 |
|